LOM
TTPH

Loeb Offshore Management’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Loeb Offshore Management’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-500
Closed -$109K – 197
2014
Q1 		$109K Buy
+500
New +$139K 0.03% 143
2013
Q4 		– Sell
-680
Closed -$155K – 253
2013
Q3 		$155K Buy
+680
New +$119K 0.05% 204

Other funds holding TTPH

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
AWMDMG
Austin W. Marxe & David M. Greenhouse New York $733M AUM 21.72% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Loeb Offshore Management's TTPH Position: Q2 2014 in Review

Loeb Offshore Management sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q2 2014, closing a stake of 500 shares — an estimated $109K sold.

Loeb Offshore Management first reported a position in TTPH in Q3 2013 and held it in 2 quarters. The position peaked at $155K in Q3 2013. 64 funds tracked by Wall St. Rank hold TTPH as of Q2 2014.

  • Loeb Offshore Management reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q2 2014 after selling out during the quarter.
  • Loeb Offshore Management sold 500 Tetraphase Pharmaceuticals, Inc. shares in Q2 2014, an estimated $109K.
  • Loeb Offshore Management first reported a position in Tetraphase Pharmaceuticals, Inc. in Q3 2013 and held it in 2 quarters.
  • Loeb Offshore Management's Tetraphase Pharmaceuticals, Inc. position peaked at $155K in Q3 2013.
  • 64 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q2 2014.

Based on Loeb Offshore Management's 13F filing for Q2 2014, filed 14 Aug 2014.